How to structure a company towards an IPO or tradesale
Rainer Kreifels ist Referent zum Thema "How to structure a company towards an IPO or tradesale" beim Biotech & Finance Forum 2006.
Preparing an IPO or Tradesale requires different preparations and structuring of the business. How can a company create a structure that keeps both IPO and tradesale options open without hindering the progression and growth of the business? At some point a decision will have to be made either way. When is that point, and what restructuring of the business is then required to take the company towards each of the exit routes?
The Biotech & Finance Forum has established itself as THE pan-European initiative allowing innovative biotech and life science businesses from across Europe to meet in a very pragmatic and direct way with an extensive audience of Europe's leading life sciences and biotech investors as well as senior executives from top pharmaceutical firms. As a long running initiative of the European Commission, the BFF is organised by Europe Unlimited in association with EuropaBio. ▪ www.e-unlimied.com